Navigation Links
Follow-up Results of Phase 2 Study of Investigational Agent, Ibrutinib, in Relapsed/Refractory Mantle Cell Lymphoma Presented at American Society of Hematology Annual Meeting
Date:12/11/2012

edian time to response to treatment with ibrutinib was 1.9 months for first PR (range of 1.4 to 9.1 months) and 5.5 months for first CR (range of 1.7 to 16.4 months).

Safety data were available for 111 patients in the trial. Patients treated with ibrutinib experienced treatment-emergent adverse events (AEs) that were consistent with previously reported data. Treatment-emergent AEs were mainly grade 1 or 2. Treatment-emergent AEs of all grades occurring in 20 percent or more patients were diarrhea, fatigue, nausea, upper respiratory tract infection and dyspnea (shortness of breath). Pneumonia was the only grade 3 or higher treatment-emergent AE occurring in 5 percent or more patients.

"We are encouraged by the rate and durability of response and the tolerability profile suggested in these Phase 2 study follow-up findings, and look forward to enrolling and seeing results from additional Phase 2 and Phase 3 trials," said Peter Lebowitz, M.D., Ph.D., Global Oncology Therapeutic Area Head, Janssen. "Our collaboration with Pharmacyclics to co-develop ibrutinib in a broad range of B-cell malignancies is part of Janssen's longstanding commitment to apply innovative science to address the most critical unmet needs."

Study Details

PCYC-1104-CA is an international, multicenter, open-label, Phase 2, single-agent study that treated 111 patients (63 bortezomib-naive patients and 48 bortezomib-exposed patients) with relapsed or refractory MCL. Patients were treated with oral ibrutinib 560 mg daily for continuous 28-day cycles until disease progression. The primary endpoint of the study is ORR, and secondary endpoints include duration of response (DOR), PFS, overall survival (OS) and safety/tolerability. The study was conducted by Pharmacyclics.

About Mantle Cell Lymphoma

MCL is an aggressive type of B-cell non-Hodgkin lymphoma (NHL) that usually occurs in middle-aged or older adults. The disease typically begins in the lymph nodes but ca
'/>"/>

SOURCE Janssen Research & Development, LLC
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Follow-up Results of Phase 2 Study of Investigational Agent, Ibrutinib, Suggest High and Durable Responses in Relapsed/Refractory Mantle Cell Lymphoma
2. Six-Year Follow-Up Data for SPRYCEL®? (dasatinib) 100 mg Once Daily Demonstrates 71 Percent Overall Survival in Patients with Chronic-Phase Chronic Myeloid Leukaemia Resistant or Intolerant to Imatinib
3. Landauer, Inc. Reports Fiscal 2012 Fourth Quarter And Year End Results
4. Ambit and Astellas Announce Presentation of Results from Phase 2 ACE Study of Quizartinib in Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML) at the 54th Annual Meeting of the American Society of Hematology
5. IRIDEX Corporation Announces Preliminary Results of its Tender Offer
6. American Pacific to Release Financial Results and Hold Fiscal 2012 Year-End and Fourth Quarter Investor Teleconference
7. PNAS Publishes Preclinical Results of EntreMeds 2ME2 for Multiple Sclerosis
8. The Female Health Company Reports Record Fourth Quarter and FY2012 Operating Results
9. ObeTherapy Announces the Publication of Results Obtained with one of its Lead Compounds on a New Target for the Treatment of Obesity and Type II Diabetes
10. InspireMD to Discuss MGuard(TM) and the MASTER Randomized Trial Results at the ICI 2012 Meeting
11. Landauer, Inc. Sets Date And Time For Announcement Of Fiscal Fourth Quarter And Full Year 2012 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2014)... DUBLIN , Nov. 21, 2014 Research ... "China Recombinant Protein Drug Industry Report, 2014-2017" report ... The Chinese recombinant protein drug market ... demand rigidity, consumption ability and the like. During 2005-2013, ... hospitals grew at a CAGR of 19.1%, and it ...
(Date:11/21/2014)... COLLEGE PARK, Md. , Nov. 21, 2014 /PRNewswire-USNewswire/ ... Engineering today will host the ceremonial groundbreaking of the ... Maryland, College Park. The new building will cultivate transformative ... human health.  Taking place at 10:00 a.m. ... building in the Paint Branch Parking Lot, adjacent to ...
(Date:11/21/2014)... 2014 In September 2014, the staff at ... a new product development plan that started with the ... lab coat , aptly named "Vera G.," after ... the world. The new women,s designer lab coat is ... sleek envelope collar, vertical princess and high waist seaming, ...
Breaking Medicine Technology:China Recombinant Protein Drug Industry Report, 2014-2017 2China Recombinant Protein Drug Industry Report, 2014-2017 3University of Maryland Breaks Ground for A. James Clark Hall 2University of Maryland Breaks Ground for A. James Clark Hall 3University of Maryland Breaks Ground for A. James Clark Hall 4Medelita Introduces Medical Industry's First Limited Edition Women's Designer Lab Coat 2
... Feb. 21, 2012  AcelRx Pharmaceuticals, Inc. (Nasdaq: ... development and commercialization of innovative therapies for the treatment ... King, President and Chief Executive Officer, will present at ... NY and one in Boston, MA, over the coming ...
...   Enanta Pharmaceuticals, Inc. , a research and ... drugs in the infectious disease field, announced today ... and license agreement with Novartis for the worldwide ... candidate, EDP-239, from its NS5A hepatitis C virus ...
Cached Medicine Technology:AcelRx Pharmaceuticals to Present at Two Near-Term Health Care Conferences 2Enanta Enters Into Strategic Collaboration to Advance NS5A Inhibitor Candidate for HCV 2Enanta Enters Into Strategic Collaboration to Advance NS5A Inhibitor Candidate for HCV 3
(Date:11/24/2014)... (PRWEB) November 24, 2014 "My friend ... was trying to cross the street in his motorized ... never saw him. I came up with this idea ... at night." , He developed the Safety Lites to ... in low-lighting conditions. The device ensures that motorists can ...
(Date:11/23/2014)... For the coming special Friday, Tidebuy, a famous wedding ... for many products, especially the beautiful colored wedding dresses ... with amazing discounts, up to 90% off. Don’t hesitate ... easy to buy colored wedding dresses in different sizes ... famous for delicate craftsmanship, elegant style and perfect lines. ...
(Date:11/23/2014)... 23, 2014 Pro Ace Care, a renowned ... will now be providing an 8 year warranty on its ... tank installations went up due to the impending winter season, ... customers of the premium service that the company provides. As ... warranty on John Wood and Bradford hot water tanks. ...
(Date:11/23/2014)... 23, 2014 (HealthDay News) -- The holidays can be ... sensory overload can trigger major meltdowns, an expert says. ... best of circumstances, but when you have children with ... an occupational therapy professor at University of the Sciences ... "It,s best to let your hosts or visitors know ...
(Date:11/23/2014)... 2014 To show thanks to new and ... of white evening dresses for weddings. Customers who ... , iFitDress.com is a distinguished dress manufacturer, and it is ... worldwide customers for a very long time. The CEO of ... customer will be able to buy not only a beautiful ...
Breaking Medicine News(10 mins):Health News:Beautiful Wedding Dresses Available at Popular B2C Company Tidebuy 2Health News:Pro Ace Care Now Gives 8 Year Guarantee on Selected Vancouver Hot Water Tanks 2Health News:Holidays Can Be Sensory Overload for Kids With Autism 2Health News:iFitDress.com: Wonderful White Evening Dresses Now Available 2
... have an exciting,new fitness option for their children this ... of the "Ultimate Fitness" program for 3 - 18 ... on the priority list of,Manhattan parents as childhood obesity ... will keep their children engaged and excited about,physical activity. ...
... Ranked Among Inc. ... NEW YORK and SAN FRANCISCO, Sept. 5 WeissComm ... announced 10 recent new hires to work on several new ... offices. The Company also announced that the 2007 survey ...
... Patient Forecast Projects Significant Expansion of Drug-Treated Population, But ... to a New ... Report from Decision Resources, WALTHAM, Mass., Sept. 5 ... on pharmaceutical and,healthcare issues, has found that a significant proportion of ...
... Succulent Morsels Paired with Delectable Sauces Satisfy Even the Most ... ... taste in mind and,health at heart, the Wellness(R) brand of natural ... Wellness(R) Healthy Indulgence,Naturally Delicious Everyday Entrees. Pairing savory sauces with real,seafood ...
... bibs, led is a top concern for parents. The problem for,parents ... Now what do I,buy? How do I keep my child clean ... 5 times everyday for meals/snacks during the first 4,years of a ... help of a Crumb Chum. Let Babies Soar!, LLC , ...
... , Alexander D. Wissner-Gross and Efthimios Kaxiras, Physical ... has shown that thin layers of ice could ... well above body temperature, which could make ice-coated-diamond ... joint replacements, and wear-resistant prosthetics. , , Physicists Alexander ...
Cached Medicine News:Health News:Keeping Kids Healthy and Fit: The New York Kids Club Launches a Revolutionary New Fitness Program 2Health News:WeissComm Partners Makes 10 New Hires as It Wins New Accounts and Grows Existing Business 2Health News:Burgeoning Population of Hepatitis C Virus Patients in Need of Second- and Third-Line Treatment Options 2Health News:Finicky Felines Award Four Stars to New Wellness(R) Healthy Indulgence Everyday Entrees 2Health News:Finicky Felines Award Four Stars to New Wellness(R) Healthy Indulgence Everyday Entrees 3Health News:Mother and Daughter Create Lead-Free/Safe Bibs and Solve Messy Mealtime Problems 2Health News:Hot ice, measuring depression, perfect invisibility and flu vaccine incentives 2Health News:Hot ice, measuring depression, perfect invisibility and flu vaccine incentives 3Health News:Hot ice, measuring depression, perfect invisibility and flu vaccine incentives 4
Corneal rust ring remover battery powered, extra burr 1.0 mm....
BD Visitec IOL Manipulator (Lester), 0.25 mm diameter tip angled 45 in, 10 mm from end (3/bx, 1 bx/ca), sterile. For positioning intraocular lenses. Sure grip handles hand ridge indicating position o...
Sinskey lens manipulator, straight. Also available in titanium....
ICL manipulator with textured micro-ball tip....
Medicine Products: